Audit 22532

FY End
2022-04-30
Total Expended
$4.75M
Findings
2
Programs
4
Year: 2022 Accepted: 2023-01-30
Auditor: Eide Bailly LLP

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
25259 2022-004 Material Weakness - ABL
601701 2022-004 Material Weakness - ABL

Contacts

Name Title Type
QNPRASBNXEM1 Crystal Wyatt Auditee
4028793281 Marty Dubas Auditor
No contacts on file

Notes to SEFA

Title: Note 4: Provider Relief Funds Accounting Policies: Note 1: Basis of Presentation - The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of the Hospital under programs of the federal government for the year ended April 30, 2022. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of the Hospital, it is not intended to and does not present the financial position, changes in net assets or cash flows of the Hospital. Note 2: Summary of Significant Accounting Policies - Expenditures reported on the Schedule are reported on the accrual basis of accounting with the exception of the HRSA COVID-19 Claims Reimbursement for the Uninsured Program, which is based on when the claim is deemed eligible as evidenced by the receipt of monies form the federal agency. Such expenditures are recognized following the cost principles contained in Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Pass-through entity identifying numbers are presented when available. De Minimis Rate Used: N Rate Explanation: The Hospital has elected not to use the 10-percent de minimis indirect cost rate allowed under the Uniform Guidance. The Hospital received amounts from the U.S. Department of Health and Human Services (HHS) through the Provider Relief Fund (PRF) program (Federal Financial Assistance Listing/CFDA #93.498) during the calendar year ended December 31, 2020. The Hospital incurred eligible expenditures and, therefore, recognized revenue in the financial statements totaling $660,516 for the year ended April 30, 2022 and $3,779,862 in previous periods. In accordance with the compliance supplement addendum, the PRF expenditures recognized on the schedule are based on the reporting to HHS for the period ending April 30, 2022, as required under the PRF program. The amount of PRF expenditures included on the schedule requires management to make estimates and assumptions that affect the reported amounts. Accordingly, such expenditures are considered a significant estimate. Estimates and assumptions may include reducing actual expenses by amounts that have been reimbursed or are obligated to be reimbursed by other sources. Actual results could differ from those estimates.

Finding Details

Finding No. 2022-004 Material Weakness: Identification of the Federal Program: Federal Assistance Listing Number 93.498 US Department of Health and Human Services COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Activities Allowed or Unallowed and Allowable Costs/Cost Principles Material Weakness in Internal Control Over Compliance and Noncompliance Reporting Material Weakness in Internal Control Over Compliance and Noncompliance Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. The terms and conditions of the CARES Act Provider Relief Fund (PRF) distributions state that funds are to only be used to prevent, prepare for, and respond to coronavirus, and that funds may only be used for healthcare related expenses or lost revenue that is attributable to the coronavirus. The Health Resources and Services Administration (HRSA) provided guidance on how an organization was to report usage of PRF distributions received. Period 1 and Period 2 reporting required an organization to illustrate how PRF funds received were used. An organization was allowed to include eligible expenditures from January 1, 2020 through December 31, 2021 depending on the period reporting. Condition: During the process of identifying expenses that were incurred to prevent, prepare for, or respond to the coronavirus pandemic, management included expenses incurred in January 2020 and February 2020 which were not supported by management in relation to prepare, prevent, or respond to coronavirus as these were incurred prior to when the Hospital began to prepare for coronavirus. Cause: The Hospital?s internal control policy did not ensure that eligible expenses followed applicable reporting guidance. Due to the amount of detailed information that was required to be compiled by management in order to enter data into the PRF reporting portal, management inadvertently included in eligible expenses amounts unrelated to prepare, prevent, and responding to the coronavirus which occurred during the months of January 2020 and February 2020. Effect: Management included amounts in the PRF reporting portal of $337,122 for January 2020 and February 2020 expenditures which were not eligible based on the terms and conditions of the PRF distributions and subsequent HRSA guidance. Questioned Costs: None reported. The total amount reported that should have been excluded was $337,122 related to costs that were incurred from January 2020 and February 2020. This error did not result in any questioned costs as the Hospital incurred and reported additional expenses on the Total Unreimbursed Expenses Attributable to Coronavirus line item, which based on testing, resulted in sufficient expenses incurred attributable to coronavirus. As a result, there were no questioned costs. Context: A nonstatistical sample of 60 expenditures were selected for testing in which there were five errors identified for expenditures prior to when the entity began to prepare for, prevent, and respond to the coronavirus. We then used the client listing to determine the total amount of expenses reported from January 2020 and February 2020 was $337,122. The Hospital then identified the eligible expenses from the Total Unreimbursed Expenses Attributable to Coronavirus line item and additional items were selected for testing from this population. Recommendation: We recommend that management continue to monitor and enhance its internal controls over federal award compliance to ensure that only eligible costs are included in reporting periods defined by HRSA. Views of Responsible Officials: Management agrees with the noted finding. However, the Hospital also incurred and reported unreimbursed expenses attributable to coronavirus of $591,058 which could be used to replace the identified January 2020 and February 2020 costs unrelated to coronavirus. Management will continue to refine its processes to more diligently review expenditures to ensure only those costs incurred during the eligibility period are included in future reporting.
Finding No. 2022-004 Material Weakness: Identification of the Federal Program: Federal Assistance Listing Number 93.498 US Department of Health and Human Services COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Activities Allowed or Unallowed and Allowable Costs/Cost Principles Material Weakness in Internal Control Over Compliance and Noncompliance Reporting Material Weakness in Internal Control Over Compliance and Noncompliance Criteria: 2 CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. The terms and conditions of the CARES Act Provider Relief Fund (PRF) distributions state that funds are to only be used to prevent, prepare for, and respond to coronavirus, and that funds may only be used for healthcare related expenses or lost revenue that is attributable to the coronavirus. The Health Resources and Services Administration (HRSA) provided guidance on how an organization was to report usage of PRF distributions received. Period 1 and Period 2 reporting required an organization to illustrate how PRF funds received were used. An organization was allowed to include eligible expenditures from January 1, 2020 through December 31, 2021 depending on the period reporting. Condition: During the process of identifying expenses that were incurred to prevent, prepare for, or respond to the coronavirus pandemic, management included expenses incurred in January 2020 and February 2020 which were not supported by management in relation to prepare, prevent, or respond to coronavirus as these were incurred prior to when the Hospital began to prepare for coronavirus. Cause: The Hospital?s internal control policy did not ensure that eligible expenses followed applicable reporting guidance. Due to the amount of detailed information that was required to be compiled by management in order to enter data into the PRF reporting portal, management inadvertently included in eligible expenses amounts unrelated to prepare, prevent, and responding to the coronavirus which occurred during the months of January 2020 and February 2020. Effect: Management included amounts in the PRF reporting portal of $337,122 for January 2020 and February 2020 expenditures which were not eligible based on the terms and conditions of the PRF distributions and subsequent HRSA guidance. Questioned Costs: None reported. The total amount reported that should have been excluded was $337,122 related to costs that were incurred from January 2020 and February 2020. This error did not result in any questioned costs as the Hospital incurred and reported additional expenses on the Total Unreimbursed Expenses Attributable to Coronavirus line item, which based on testing, resulted in sufficient expenses incurred attributable to coronavirus. As a result, there were no questioned costs. Context: A nonstatistical sample of 60 expenditures were selected for testing in which there were five errors identified for expenditures prior to when the entity began to prepare for, prevent, and respond to the coronavirus. We then used the client listing to determine the total amount of expenses reported from January 2020 and February 2020 was $337,122. The Hospital then identified the eligible expenses from the Total Unreimbursed Expenses Attributable to Coronavirus line item and additional items were selected for testing from this population. Recommendation: We recommend that management continue to monitor and enhance its internal controls over federal award compliance to ensure that only eligible costs are included in reporting periods defined by HRSA. Views of Responsible Officials: Management agrees with the noted finding. However, the Hospital also incurred and reported unreimbursed expenses attributable to coronavirus of $591,058 which could be used to replace the identified January 2020 and February 2020 costs unrelated to coronavirus. Management will continue to refine its processes to more diligently review expenditures to ensure only those costs incurred during the eligibility period are included in future reporting.